Profil
Bernard Beer, Ph.D.
is a co-founder and has served as director and co-chairman of our board of directors since our inception in April 1995 and as president throughout this period until his retirement as president in March 2004.
Dr. Beer will resign from our board of directors effective March 15, 2005.
Dr. Beer provides consulting services to us as needed.
Prior to his retirement Dr. BeerR17;s employment terms were the same as Dr. LippaR17;s.
From 1977 to 1995, Dr. Beer was employed by American Cyanamid, now Wyeth, and served as its Global Director of Central Nervous System Biological and Clinical Research.
Dr. Beer has extensive experience in pharmaceutical research starting at Squibb Corporation from 1966 to 1976 where he was section head, Neuropsychopharmacology.
He is currently an adjunct professor of psychiatry at the New York University School of Medicine and a special professor in pharmacology at Boston University Medical School.
Dr. Beer received his B.A.
from Brooklyn College in 1956 and his M.S.
and Ph.D.
from The George Washington University in 1961 and 1966, respectively.
Anciens postes connus de Bernard Beer
| Sociétés | Poste | Fin |
|---|---|---|
DOV Pharmaceutical, Inc.
 DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | Fondateur | - |
Formation de Bernard Beer
| Brooklyn College | Undergraduate Degree |
| George Washington University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ. | Commercial Services |